Cures Within Reach Repurposing Research to Improve Patient Outcomes in Meniere’s Disease and Related Diagnoses: Clinical and Preclinical Projects
Research Admin Offices:
CWR is accepting budgets of up to $100,000 for clinical trials and budgets up to $50,000 for preclinical projects for this RFP, which includes the required 20% institutional match.
- Health Sciences
Internal Deadline:February 15, 2023
Sponsor Deadline:March 1, 2023
This Request for Proposals (RFP) from Cures Within Reach (CWR) is seeking both clinical repurposing trials and preclinical repurposing projects to address Meniere’s disease (MD) as well as other vertigo and hearing loss-related diagnoses, such as benign paroxysmal positional vertigo (BPPV), tinnitus, labyrinthitis and vestibular neuritis, to improve patient outcomes. Repurposed therapies must be approved and/or generally recognized as safe for human use by some regulatory agency, such as the US Food and Drug Administration, European Medicines Agency, Health Canada or Japan’s Pharmaceuticals and Medical Devices Agency, and can include drugs, devices, nutraceuticals, diagnostics or combination therapies.
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.